Vaccines, blood, antisera, toxins and cultures in South Korea | The Observatory of Economic Complexity

About

Exports In 2022, South Korea exported $7.4B in Vaccines, blood, antisera, toxins and cultures, making it the 10th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 13th most exported product in South Korea. The main destination of Vaccines, blood, antisera, toxins and cultures exports from South Korea are: United States ($1.37B), Switzerland ($816M), Germany ($587M), Italy ($546M), and Turkey ($498M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of South Korea between 2021 and 2022 were Switzerland ($655M), Chinese Taipei ($352M), and Australia ($325M).

Imports In 2022, South Korea imported $4.52B in Vaccines, blood, antisera, toxins and cultures, becoming the 17th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 16th most imported product in South Korea. South Korea imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($1.16B), United States ($937M), Turkey ($429M), Germany ($410M), and Switzerland ($354M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for South Korea between 2021 and 2022 were Singapore ($115M), Turkey ($70.7M), and Ireland ($69.3M).

Latest Trends

September 2024

About

Overview In September 2024 South Korea's Vaccines, blood, antisera, toxins and cultures exports accounted up to $569M and imports accounted up to $436M, resulting in a positive trade balance of $134M. Between September 2023 and September 2024 the exports of South Korea's Vaccines, blood, antisera, toxins and cultures have increased by $143M (33.5%) from $427M to $569M, while imports decreased by $-160M (-26.8%) from $595M to $436M.

Destinations In September 2024, Vaccines, blood, antisera, toxins and cultures were exported mostly to Hungary ($133M), United States ($72.6M), Germany ($65.6M), Belgium ($44.1M), and Turkey ($40.3M), and were imported mostly from Belgium ($163M), United States ($61.2M), Ireland ($44.8M), Germany ($33.9M), and Switzerland ($24.1M).

Growth In September 2024, the increase in Vaccines, blood, antisera, toxins and cultures's year-by-year exports was explained primarily by an increase in exports to Switzerland ($35.2M or 333%), United States ($26.1M or 39%), and Belgium ($24.5M or 208%). In September 2024, the decrease in Vaccines, blood, antisera, toxins and cultures's year-by-year imports was explained primarily by a decrease in imports from Belgium ($-47.7M or -71.6%), Switzerland ($-15M or -34%), and Singapore ($-10.5M or -98.3%).

Subnational Monthly Trade

Time Scale

Year

Quarter

Month

Flow

Exports

Imports

Color

Trade Value

Growth

Growth (%)

EXPORT GROWTH (September 2023 - September 2024)$143M(33.5%)

IMPORT GROWTH (September 2023 - September 2024)$-160M(-26.8%)

MAIN DESTINATION (September 2024)Hungary$133M

This section shows Vaccines, blood, antisera, toxins and cultures's exports and imports data at subnational level for South Korea. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, blood, antisera, toxins and cultures over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download